Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 TEXT SIZE: 
 HOME  SITE INDEX  CONTACT US
  
 information for researchers
Link to the National Institutes of Health Link to the Department of Health and Human Services
Skip left side navigation and go to content
Dataset Home
List of Available Datasets

All Studies

Observational Studies

Clinical Trials
Procedures for Obtaining Datasets
NHLBI Limited Access Data Policy
Funding Mechanisms for Limited Access Investigators
Institutional Review Board Approval
Teaching Dataset
Limited Access Data Policy, Data Set Preparation & Procedures FAQ

The Hypertension Detection and Follow-up Program (HDFP)

Objectives:

This program was designed to test the efficacy of antihypertensive therapy in reducing all-cause mortality in a population-based study.

Background:

Several studies have indentified elevated arterial blood pressure as a prominent risk factor for morbidity and mortality from all causes in general, and cardiovascular disease in particular. However, they were not designed to determine whether reduction of blood pressure was accompanied by reduction of disease and death.

Subjects:

A population-based screening in 14 communities recruited 10,940 hypertensive participants, aged 30-69. They were randomly assigned to Stepped Care or Referred Care groups within each center by entry diastolic blood pressure.

Conclusions:

The systematic effective management of hypertension has a great potential for reducing mortality for the large numbers of people with high BP in the population, including those with mild hypertension (JAMA 1979; 242:2562-2571).

 
Links

Study Website

Study Documentation

Data Distribution Agreement

Skip footer links and go to content

HOME · SEARCH · ACCESSIBILITY · SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT US